Tegaserod (Zelnorm) safety profile in pediatric patients

被引：0

作者：

Har, Aileen F. ^{[1
]}

Steffen, Rita ^{[1
]}

Kaplan, Barbara ^{[1
]}

Mahajan, Lori ^{[1
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2007年 / 102卷

关键词：

D O I：

10.14309/00000434-200709002-01041

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1041

引用

页码：S500 / S500

页数：1

共 50 条

[11] Ischemic colitis following use of tegaserod (Zelnorm) in a patient with narcotic-induced gastroparesis
Rahim, NA
Foster, E
Trudeau, W
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S221 - S221
[12] Safety Profile of Tegaserod (Zelmac®) from a Local Adherence Program in Mexico
Barrera-Islas, G. A.
Fon-Mendez, F. H.
Fuentes-Vargas, M. C.
DRUG SAFETY, 2009, 32 (10) : 986 - 987
[13] No increased risk of abdominal or pelvic surgery associated with tegaserod exposure:: The Zelnorm™ epidemiological study
Seeger, John D.
Quinn, Sherry
Lievano, Fabio
Rivero, Elena
Earnest, David L.
Shetzline, Michael
Holden, William
Walker, Alexander M.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S12 - S13
[14] Suspension of the production, sale and use of Zelnorm [tegaserod] has been ordered by the Chinese FDA
Reactions Weekly, 2007, 1157 (1) : 3 - 3
[15] A double-blind, randomized trial of Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease
Sullivan, KL
Staffetti, JF
Hauser, RA
Maldonado, JL
Dunne, PB
Zesiewicz, TA
MOVEMENT DISORDERS, 2004, 19 : S279 - S279
[16] Zelnorm - Tegaserod maleate - Novartis - Second IBS drug approved, this time for constipation predominant illness
不详
FORMULARY, 2002, 37 (09) : 437 - 437
[17] The US FDA is permitting the restricted use of Zelnorm [tegaserod] under a treatment investigational new drug protocol
Reactions Weekly, 2007, 1163 (1) : 2 - 2
[18] Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data
Lacy, Brian E.
Brenner, Darren M.
Chey, William D.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (04) : E682 - E695
[19] OVERVIEW OF THE SAFETY PROFILE OF CLARITHROMYCIN SUSPENSION IN PEDIATRIC-PATIENTS
CRAFT, JC
SIEPMAN, N
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (12) : S142 - S147
[20] Pharmacokinetics, Safety Profile, and Efficacy of Aliskiren in Pediatric Patients With Hypertension
Sullivan, Janice E.
Keefe, Deborah
Zhou, Yinong
Satlin, Lisa
Fang, Hui
Yan, Jing-He
CLINICAL PEDIATRICS, 2013, 52 (07) : 599 - 607

← 1 2 3 4 5 →